PT Trimitra Prawara Goldland Tbk (ATAP.JK)
IDR 27.0
(0.0%)
IDR 27.0
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -3.43 Billion | -5.64 Billion | 8.5 Billion | -19.54 Billion | 6.94 Billion | 4.75 Billion |
| Net Income | 162.82 Million | 2.15 Billion | 5.52 Billion | 3.39 Billion | 19.74 Billion | 13.36 Billion |
| Depreciation & Amortization | 507.02 Million | 556.21 Million | 498.66 Million | 548.83 Million | 373.43 Million | 247.87 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | - | - | - | - |
| Other non-cash items | -4.1 Billion | -7.24 Billion | 3.48 Billion | -22.38 Billion | -12.42 Billion | -8.36 Billion |
| Investing Cash Flow | -46.1 Million | -1.6 Billion | 121.01 Million | -226.65 Million | -984.72 Million | -2.77 Billion |
| Investments in PPE | -46.1 Million | -1.91 Billion | -140.98 Million | -226.65 Million | -984.72 Million | -2.77 Billion |
| Acquisitions | - | 309 Million | 262 Million | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | -41 Million | 262 Million | - | -163.32 Million | -175 Million |
| Financing Cash Flow | -131.19 Million | 18.32 Billion | -8.27 Billion | 19.72 Billion | -6.99 Billion | -3.62 Billion |
| Debt repayment | -18.8 Million | -20.57 Billion | -9.25 Billion | -1.65 Billion | -2.84 Billion | -2.29 Billion |
| Dividends payments | -150 Million | -812.5 Million | -492.43 Million | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | 22.22 Billion | - | - |
| Other Financing Activities | 1.00 | -1.43 Billion | 1.46 Billion | -4.16 Billion | -4.14 Billion | -1.33 Billion |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 14.57 Billion | 3.5 Billion | 3.15 Billion | 3.2 Billion | 4.22 Billion | 5.88 Billion |
| Cash at end of period | 10.96 Billion | 14.57 Billion | 3.5 Billion | 3.15 Billion | 3.2 Billion | 4.22 Billion |
| Capital Expenditure | -46.1 Million | -1.91 Billion | -140.98 Million | -226.65 Million | -984.72 Million | -2.77 Billion |
| Effect of forex changes on cash | -1.00 | - | -1.00 | 1.00 | - | - |
| Net cash flow / Change in cash | -3.61 Billion | 11.07 Billion | 352.85 Million | -50 Million | -1.02 Billion | -1.65 Billion |
| Free Cash Flow | -3.48 Billion | -7.56 Billion | 8.36 Billion | -19.77 Billion | 5.96 Billion | 1.97 Billion |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -80.33 Million | 6.38 Million | 130.23 Million | -175.64 Million | 162.82 Million | 45.39 Million |
| Depreciation & Amortization | 163.81 Million | 109.37 Million | 179.59 Million | 235.03 Million | 685.52 Million | 146 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | - | - | - | - |
| Other non-cash items | -289.09 Million | 2.42 Billion | -142.61 Million | -1.63 Billion | -2.91 Billion | 646.42 Million |
| Investing Cash Flow | -5.86 Million | - | -9.74 Million | -6.2 Million | -46.1 Million | -35.14 Million |
| Investments in PPE | -5.86 Million | - | -9.74 Million | -6.2 Million | -46.1 Million | -35.14 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 1.58 Billion | -3.16 Billion | -960 Million | 736.83 Million | -131.19 Million | -2.71 Billion |
| Debt repayment | -1.58 Billion | -3.16 Billion | -814 Million | -601.1 Million | -18.8 Million | -2.43 Billion |
| Dividends payments | - | - | - | - | -150 Million | -150 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -1.00 | -36.5 Million | -146 Million | 135.73 Million | 1.00 | -135.73 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 9.17 Billion | 9.8 Billion | 10.96 Billion | 12.27 Billion | 14.57 Billion | 14.48 Billion |
| Cash at end of period | 10.55 Billion | 9.17 Billion | 9.8 Billion | 10.96 Billion | 10.96 Billion | 12.27 Billion |
| Capital Expenditure | -5.86 Million | - | -9.74 Million | -6.2 Million | -46.1 Million | -35.14 Million |
| Effect of forex changes on cash | - | - | - | - | -1.00 | - |
| Net cash flow / Change in cash | 1.37 Billion | -626.11 Million | -1.16 Billion | -1.31 Billion | -3.61 Billion | -2.2 Billion |
| Free Cash Flow | -211.48 Million | 2.53 Billion | -201.72 Million | -2.04 Billion | -3.48 Billion | 510.67 Million |
CBSM
MHKI
605128
OILRF
CORA
PPLPHARMA